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Introduction
 Vaccination enormously successful
 Smallpox eradicated, polio close
 More to do
 15 M people still die annually, half children <5 yrs
 Emergent and re-emergent disease
 Technological gap in approaches
 Pasteur’s “Isolate-Inactivate-
































in literature: 1 mg/L.OD
After factorial optimisation,
Host selection and redesign:
15-20 mg/L.OD
Confirmed 2-4 g/L in fed-batch
E. coli fermentation.
J. Biotechnol. (2008), 134(1-2): 64-71
J. Biotechnol. (2010), 150(2): 224-231






















 same process for different viruses
 time from DNA to purified antigen < 1 week
 processing can be automated
The UQ Microbial Vaccine Platform (MVP)
Scale
 Makes protein using industrial biotechnology tools
 100M doses per kL of bacterial culture in 
Safety
 we make protein, not virus
 we can sterile filter before virus assembly
9
24 h

















Everyone can cultivate bacteria.
















































































































































































When the virus changes, existing vaccine does not work.
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http://microbiology2009.wikispaces.com/Influenza
H1N1 (2009): April 27th
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H1N1 (2009): May 27th
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H1N1 (2009): September 27th
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Influenza in a Connected World
Share
Identify



















HA1 – receptor binding regions
Other HA1 epitopes
 Somewhat Universal










 Receptor binding site.
 Biology 101 – blocking 
the receptor binding site 




















Structural analysis of helix 190 peptide
MD simulation
 Gromacs

























































































 Trypsin digestion site
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 Antigen insertion:



















































































































































 Little sensitivity to more 
 Excellent IgG titres
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Alhydrogel







 VLP and capsomere platform developed
 Remarkable productivity, protein not virus based
 Excellent developability and manufacturability
 Excellent end point titres
 Moving to protection studies
 Multitude of insertions successfully handled
 Flexibility afforded by VLP and Capsomere formats
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